Live from ESMO 2023 | Oral Report Featuring Latest Data of P

SUZHOU, China and ROCKVILLE, Md., Oct. 23, 2023 /PRNewswire/ -- Ascentage Pharma , a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B , and...

Related Keywords

China , Australia , Beijing , Rockville , Western Australia , Suzhou , Jiangsu , Madrid , Spain , Hong Kong , Yifan Zhai , Prnewswire Ascentage Pharma , Ascentage Pharma , Major National , National Reimbursement Drug List , Astrazeneca , China National Medical Products Administration , European Society Of Medical Oncology , Dana Farber Cancer Institute , Md Anderson Cancer Center , Mini Oral , Medical Oncology , Chief Medical Officer , Madrid Time , Beijing Time , Main Board , Stock Exchange , Hong Kong Limited , Major National Rd Projects , Major New Drug Projects , New Drug Incubator , Innovative Drug Programs , Major Project , Priority Review Designations , Breakthrough Therapy Designations , Drug Evaluation , Reimbursement Drug List , Orphan Drug Designation , Fast Track Designation , Orphan Designation , Pediatric Disease , Cancer Center , Mayo Clinic , Markets ,